Emergent BioSolutions (EBS) Goodwill (2010 - 2023)

Emergent BioSolutions has reported Goodwill for 14 years, with the latest figure at $218.2 million in Q2 2023.

• On a quarterly basis, Goodwill fell 2.98% year-over-year to $218.2 million in Q2 2023; TTM through Jun 2023 was $218.2 million, a 2.98% decrease from a year earlier, with the FY2022 full-year figure at $218.2 million, down 2.98% from the prior year.
• Goodwill was $218.2 million for Q2 2023 at Emergent BioSolutions, roughly flat from $218.2 million in the prior quarter.
• The five-year high for Goodwill was $268.6 million in Q3 2019, with the low at $218.2 million in Q4 2022.
• Average Goodwill over 5 years is $249.5 million, with a median of $266.4 million recorded in 2020.
• The sharpest annual moves came in 2019 and 2021: Goodwill surged 446.71% in 2019, then declined 15.67% in 2021.
• Over 5 years, Goodwill stood at $266.6 million in 2019, then advanced by 0.04% to $266.7 million in 2020, then slipped by 15.67% to $224.9 million in 2021, then decreased by 2.98% to $218.2 million in 2022, then changed by 0.0% to $218.2 million in 2023.
• The last three Goodwill figures came in at $218.2 million (Q2 2023), $218.2 million (Q1 2023), and $218.2 million (Q4 2022), per Business Quant data.